US Virgin Islands IPP: Use of Limited Resources Taetia Phillips-Dorsett, MS Territorial Director, USVI DOH STD/HIV/TB Program Region II IPP Advisory Meeting.

Slides:



Advertisements
Similar presentations
HIV Counselling and Testing
Advertisements

WI State Report RVIPP, Indianapolis, IN June 9-10, 2010.
Improving STD Screening Rates in the HIV Clinics C. Lynn Besch, MD for the LSUHSC HIV Disease Management Team.
Clinical Alliances and Partnerships Raul A. Romaguera, DMD, MPH Division of HIV/AIDS Prevention Centers for Disease Control and Prevention March 11, 2004.
Implementing a Gonorrhea and Chlamydia Screening Program in Philadelphia Public High Schools Melinda Salmon Philadelphia Department of Public Health.
813 Wake County Lessons Learned and What’s to Come.
Assessment of Chlamydia Rescreening Practices Kelly Opdyke, MPH Region II IPP Advisory Committee Mtg May 16-17, 2007 Cicatelli Associates Inc.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
A Cost-Effectiveness Evaluation of the Sexually Transmitted Disease (STD) Prevention Program at the Hampden County Correctional Center, Massachusetts Gift.
Revision of Region II IPP Screening Criteria May 16, 2007 Region II IPP Advisory Committee Meeting Cicatelli Associates Inc. New York City.
OPA/OFP HIV Prevention Project Annual Technical Support Conference Report from Breakout Sessions – Day 1 Karla Johnson, MSPH Executive Director Development.
Repeat Chlamydial Infections in Region III Family Planning Clinics: Implications for Screening Programs Pamela G. Nathanson, Family Planning Council, Inc.
STD Services in Detention in Los Angeles County Melina R. Boudov, MA Project Director LA County Infertility Prevention Project
The CDC Prevention Grant Funding Opportunity Announcement (FOA) and OA’s Response Overview and Discussion September 21, 2011 California Department of Public.
Screening males for chlamydial infection in detention settings Charlotte K. Kent, MPH.
Using Test Kit Allotments to Reduce Chlamydia Screening in Low Risk Females for Re-allocation to Higher Risk Populations and Higher Yield Venues Rabins.
Appropriate CT/GC Screening & Factors to Consider Becky McCoy MSN, RN, CEN STD Nurse Consultant.
Use of an Internet-Based Self-Screening Program to Screen for Chlamydia and Gonorrhea Wendy Voet On Behalf Of Charlotte A. Gaydos and Karen Dwyer, Mathilda.
Analysis of Chlamydia Re-testing Rates Massachusetts Family Planning Update.
Reaching Out to Providers Summary of Region II IPP Tools.
STEP UP: NYC DOHMH STD School Screening Progress Meighan Rogers, MPH IPP Region II Mtg December, 2007.
Re-Screening of CT Positive Clients in Region X IPP, Goldenkranz S., 1 Fine D. 1 1 Center for Health Training 2010 CDC STD Prevention Meeting,
Gonorrhea Epidemiology and Prevention Program Efforts in Iowa
Trends in Clinic Visits and Diagnosed C. trachomatis and N. gonorrhoeae Infections Following the Introduction of a Co-Pay in an STD Clinic C. Rietmeijer.
1 OPA/OFP HIV Prevention Project Annual Technical Support Conference Six Years of HIV Supplemental Grants – A National Perspective Susan B. Moskosky Director,
Results from the ACHA Pap Test and STI Survey for Calendar Year 2008 American College Health Association Sexual Health Education and Clinical Care Coalition.
Region I IPP Infrastructure Updates Advisory Board Meeting November 12, 2009 Boston, MA.
Region I IPP Clinic Staff and Provider Assessment Kim Watson, Jennifer Kawatu.
Increasing the Efficiency of STI Clinics by Tailoring Services Based on a Risk Triage System Julie A. Subiadur, BSN, CCRC BC Brandy Mitchell, RN Dean McEwen.
1 TITLE X FAMILY PLANNING/HIV INTEGRATION PROJECT Opt Out Process Michael Brannon M.S. HIV/STD Prevention Program Manager (713)
State and Local STD Prevention Programs Prepared by Jim Lee, Senior Public Health Advisor, Texas Department of State Health Services and Melinda Salmon,
BUDGET UPDATE & DISCUSSION Roxanne Ereth, MPH STD Control Program Manager September 2, 2009.
GC Outbreak in Philadelphia Greta Anschuetz, MPH Philadelphia Department of Public Health
Region I IPP Infrastructure Updates Advisory Board Meeting June 15, 2010 Boston, MA.
Collecting Site Positivity Data in Region I Andee Krasner, MPH Region I IPP Advisory Board Meeting.
Region II IPP Data & Infrastructure Performance Measures Kelly Opdyke, MPH Region II IPP Advisory Committee Mtg May 16-17, 2007 Cicatelli Associates Inc.
Region I Infertility Prevention Project June 9-10, 2008 Wells Beach, Maine Steven J. Shapiro Infertility Prevention Project Coordinator CDC/CCID/NCHHSTP/DSTDP/PTB.
IPP Measures of Effectiveness Utilization of Data to Evaluate and Inform Project Activities December 12, 2007 Kelly Morrison Opdyke, MPH Region II Infertility.
Infrastructure Update Jennifer Kawatu Kim Watson Andee Krasner
Targeting Chlamydia Screening Resources Region II IPP Advisory Meeting May 31, 2006 Kelly Opdyke, MPH Cicatelli Associates Inc.
BASELINE ASSESSMENT OF CHLAMYDIA REINFECTION IN REGION VIII FAMILY PLANNING CLINICS FOR Hamby, Y, JSI Research & Training Institute Donovan,
Reaching Adolescents Michigan’s Infertility Prevention Screening Project.
1 MSM Sexual Health Summit August 20, 2012 HIV/STD Prevention and Care Branch Texas Department of State Health Services.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 1999 Division of STD Prevention.
Philadelphia High School STD Screening Program Declining Disease Prevalence After 4 Years of Screening Lenore Asbel, Melinda Salmon, C. Victor Spain, Christa.
1. USVI’s Gonorrhea Surveillance Or, What is going on down there in America’s Paradise? 2.
STD’s in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2001 Division of STD Prevention.
Gonorrhea Morbidity and Prevention Efforts in Los Angeles County Binh Goldstein, PhD, Epidemiologist Sarah Guerry, MD, Medical Director Sexually Transmitted.
High prevalence rate of Trichomoniasis Vaginalis in an urban HIV clinic Debbie Mohammed, DrPH, MS, MPH, AACRN Prerak Shukla, MBBS Maria Szabela, MD Jihad.
Presenter Carolyn Tunstall, IPP Coordinator November 9, 2009 GC Prevention Activities In New Jersey.
NYC DOHMH BSTDC School-Based Education, Screening and Treatment Pilot Program Meighan Rogers, MPH Bureau of STD Control, NYC DOHMH Region II IPP Meeting,
Region I IPP Data Presentation Advisory Board Meeting June 2008 Wells, ME.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2007 Division of STD Prevention.
Chlamydia Screening in Indian Country Regional Role in Promoting and Supporting Stop Chlamydia Project Activities Yvonne Hamby, MPH Region VIII Infertility.
Region II Infertility Prevention Project Advisory Committee May 16-17, 2007 New York, New York Steven J. Shapiro Infertility Prevention Project Coordinator.
IPP Infrastructure Measures of Effectiveness: Preliminary Data and Next Steps Kelly Morrison Opdyke, MPH Region II Infertility Prevention Project Cicatelli.
Check Your Risk: Increasing School-Based STI Screening Participation Among District of Columbia High School Students Michelle Jasczyński, Ed.M. Public.
Gonococcal Isolate Surveillance Project (GISP)
It's not what you know, but who you know: Risk factors for re-infection in the Philadelphia High School STD Screening Program Jennifer Beck, MPH APHA.
Universal Screening to Assess Chlamydia Prevalence and Risk Among Older Women Attending Family Planning Clinics in Wisconsin Roberta (Bobbie) McDonald.
Cost of Screening Outside of IPP Chlamydia Screening Guidelines
Martin Goldberg1, Daniel R. Newman2, TA Peterman2,
Division of STD/HIV/AIDS Chicago Department of Public Health
Infertility Prevention Project Coordinator CDC/CCID/NCHHSTP/DSTDP/PTB
Region II IPP Performance Measure IPP CS1 and IPP CS2 Project Area Trend Report IPP CS1: Timely treatment of women with chlamydia at IPP Family Planning.
Promoting Sexual Health in NYS
Region I IPP Data Update Region I IPP Advisory Board Meeting
Treatment Verification Rates for Chlamydia and Gonorrhea
Gonorrhea Screening: What Do the Data Tell Us?
Presentation transcript:

US Virgin Islands IPP: Use of Limited Resources Taetia Phillips-Dorsett, MS Territorial Director, USVI DOH STD/HIV/TB Program Region II IPP Advisory Meeting November 1, 2006

USVI IPP Program Operations Publicly Funded IPP Screening Venues: – STD Clinics, FP Clinics, Prenatal Sites, Community Health Centers Treatment: – $6.00/dose for Azithromycin – FY2006 local govm’t allotment for STD meds=$8,000 ($7,360 actually spent) Test Technology: – Gen-Probe APTIMA CT/GC Combo – Cost: $14.00 per test Budget: – USVI has been actively addressing budget issues related to securing and forwarding payment to the New Jersey DHSS for laboratory screening services.

USVI IPP Screening Criteria Because of budget challenges USVI did not follow the recommended Region II IPP Screening Criteria from March 2005 through July In March of 2005, in consultation with CDC, the USVI issued a memo to all participating clinical sites to test clients in the following categories: – Pregnant Females – Symptomatic Individuals, and – Contacts to persons confirmed with Gonorrhea and Chlamydia

Impact of March 2005 Criteria Overall decline in test volume and case identification: 28% decline in testing volume – from 4,453 tests in CY2004 to 3,207 tests in CY % reduction in identification of positive CT cases – from 597 cases in CY2004 to 476 cases in CY % reduction in identification of positive GC cases – from 129 cases in CY2004 to 59 cases in CY2005

Impact of March 2005 Criteria (cont’d) Marked decline in test volume and case identification in FP and among females: 50% decline in testing of females in FP clinics – from 2,103 tests in CY2004 to 1,061 in CY % decline in testing among females age – from 2,003 tests in CY2004 to 1,392 tests in CY % reduction in identification of positive CT cases in FP – from 236 cases in CY2004 to 159 cases in CY % reduction in identification of positive GC cases in FP – from 44 cases in CY2004 to 17 cases in CY2005.

# of CT/GC Tests* Among Females by HCPT and Year, USVI IPP (N = 10,055) *Includes tests with valid (positive or negative) CT results only.

Chlamydia Positivity* Among Females by HCPT and Year, USVI IPP (N = 10,055) *Adjusted for change in lab test type in 2003 from PACE to APTIMA N = 3,199 N = 3,988 N = 2,868

Gonorrhea Positivity* Among Females by HCPT and Year, USVI IPP (N = 10,089) *Adjusted for change in lab test type in 2003 from PACE to APTIMA N = 3,211 N = 3,999 N = 2,879

Implications of Underscreening FP sites in particular noted that they were not able to screen new clients who had never had a chlamydia test because they did not fit the March 2005 criteria. A clinical provider at the largest FP site on St. Croix noted a dramatic increase in diagnosis of PID for uninsured women: she recorded more than twice as many cases of PID in the first 5 months of 2006 (17 cases) as she recorded in all of CY2005 (8 cases). In addition, staff expressed concern about the increased risk of HIV acquisition in the face of an undetected and untreated Chlamydial infection.

Preliminary Analysis of # Tests Needed to Support Implementation of New Criteria VenueScreening CriteriaAnnual # Tests MalesFemales STDAll<29 yrs630 FPNone<24 yrs1,200 Other Sites (CHC) None<24 yrs600 PrenatalNoneAll ages 1 st & 3 rd trimester 700 (CY2005 data) TOTAL (excluding Prenatal)2,430 Note: Current IPP budget can support 2,600 tests annually.

Plan for Test Kit Allocation and Revised Screening Criteria – July 2006 VenueScreening CriteriaAnnual # Tests MalesFemales STDAll<29 yrs800 (625 swab, 175 urine) FPNone<24 yrs1,200 Other Sites (CHC) None<24 yrs600 PrenatalNoneAll ages 1 st & 3 rd trimester Supported by local STD funds TOTAL (excluding Prenatal)2,600 Note: Current IPP budget can support 2,600 tests annually.

Additional Guidelines for Screening Venues (FP, STD, & CHC) – July 2006 Treat all symptomatic females and males -Males to be tested only at STD clinic sites DO NOT test symptomatic clients DO NOT test clients outside age criteria Recommendation (FP): – Offer each client meeting criteria only 1 free IPP test per year. – FP to identify funds for additional screening once IPP allotment has been exhausted – Creation of an STD screening the STJ DOH clinic to ensure availability to males for both screening & treatment on island with most limited resources

Next Steps Monitor implementation of revised guidelines Monitor test kit allocation system Identify additional sources of funding needed to expand screening program and maintain screening in prenatal clinics - VI Gov has allotted $35,000 suppl. funding for ~2,500 additional tests territory wide - VI Gov has allotted $22,000 suppl. funding for purchase of STD related medications bringing total budget to $30,000 (4x prior year funding). This will allow for routine distribution of meds supply to clinics. Explore evidence of increase in PID - FP currently monitoring in STX, STD clinics have begun monitoring